Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
V03AE10
|
| gptkbp:brand |
gptkb:Lokelma
|
| gptkbp:CASNumber |
2075997-61-8
|
| gptkbp:chemicalFormula |
Na12[(AlO2)12(SiO2)12]·27H2O
|
| gptkbp:form |
powder for oral suspension
|
| gptkbp:genericName |
gptkb:sodium_zirconium_cyclosilicate
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lokelma
|
| gptkbp:indication |
hyperkalemia
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
potassium binder
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:prescribes |
adults
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gastrointestinal discomfort
edema hypokalemia |
| gptkbp:usedFor |
treatment of hyperkalemia
|
| gptkbp:bfsParent |
gptkb:AstraZeneca_US
|
| gptkbp:bfsLayer |
6
|